Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group.

E, Modigliani; HM, Vasen; K, Raue; H, Dralle; A, Frilling; RG, Gheri; ML, Brandi; E, Limbert; B, Niederle; L, Forgas

doi:10.1111/j.1365-2796.1995.tb01211.x

Public

Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group.

Shared by NobleBlocks on Oct 1, 1995 • 12:00 AM UTC

Authors:

Modigliani E

Vasen HM

Raue K

Abstract

Objectives Pheochromocytoma (pheo) is the second component of the multiple endocrine neoplasia type 2 (MEN 2) syndrome. Clinical expression is sometimes poor, and chronology between medullary thyroid carcinoma (MTC) and pheo is not well evaluated. Therefore, a retrospective study was done in eight E...

Discussions